Old drug, new indication: Olsalazine sodium reduced serum uric acid levels in mice via inhibiting xanthine oxidoreductase activity
Open Access
- 1 November 2017
- journal article
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 135 (3) , 114-120
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81260503, 81360505)
- Yunnan Provincial Department of Education Research (2014Z064)
- The Vice-Chancellor's One-off Discretionary Fund
- Faculty of Social Science Postdoctoral Fellowship Scheme
- Institute of Future Cities, The Chinese University of Hong Kong
This publication has 24 references indexed in Scilit:
- ZINC: A Free Tool to Discover Chemistry for BiologyJournal of Chemical Information and Modeling, 2012
- The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical GenomicsScience Translational Medicine, 2011
- 3,5,2′,4′-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitorChemico-Biological Interactions, 2011
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Flavonoids of Cynara scolymus Possess Potent Xanthinoxidase Inhibitory Activity in vitro but are Devoid of Hypouricemic Effects in Rats after Oral ApplicationPlanta Medica, 2008
- FebuxostatDrugs, 2008
- Administration of Procyanidins from Grape Seeds Reduces Serum Uric Acid Levels and Decreases Hepatic Xanthine Dehydrogenase/Oxidase Activities in Oxonate‐Treated MiceBasic & Clinical Pharmacology & Toxicology, 2004
- Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?Hypertension, 2003
- The Protein Data BankNucleic Acids Research, 2000
- Substituted cyclic imides as potential anti-gout agentsLife Sciences, 1990